Osteomyelitis: An overview of antimicrobial therapy

Brazilian Journal of Pharmaceutical Sciences

Volumn 49, Issue 1, 2013, Pages 13-27

  Gomes, Diana ^a   Pereira, Margarida ^b   Bettencourt, Ana Francisca ^a  

^a RESEARCH INSTITUTE FOR MEDICINES IMED ULISBOA   (Portugal)

^b HOSPITAL DE SANTA CRUZ   (Portugal)

Author keywords

Antibiotics use osteomyelitis treatment; Osteomyelitis antimicrobial therapy; Osteomyelitis pharmacological treatment; Staphylococcus aureus presence Osteomyelitis

Indexed keywords

AMPICILLIN; ANTIINFECTIVE AGENT; BETA LACTAM ANTIBIOTIC; CEFALEXIN; CEFEPIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLINDAMYCIN; DALFOPRISTIN PLUS QUINUPRISTIN; DAPTOMYCIN; FUSIDIC ACID; GATIFLOXACIN; GEMIFLOXACIN; GENTAMICIN; GLYCYLCYCLINE DERIVATIVE; LEVOFLOXACIN; LINEZOLID; MOXIFLOXACIN; OFLOXACIN; PEFLOXACIN; PENICILLIN DERIVATIVE; PENICILLIN G; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; STREPTOGRAMIN DERIVATIVE; TIGECYCLINE; UNINDEXED DRUG; VANCOMYCIN;

BACTERIAL INFECTION; DISEASE MODEL; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG PENETRATION; DRUG SAFETY; ENTEROBACTERIACEAE; HUMAN; NONHUMAN; OSTEOMYELITIS; PATHOGENESIS; PATHOPHYSIOLOGY; PSEUDOMONAS; REVIEW; STAPHYLOCOCCUS; UNSPECIFIED SIDE EFFECT;

EID: 84876911023     PISSN: 19848250     EISSN: 21759790     Source Type: Journal    
DOI: 10.1590/S1984-82502013000100003     Document Type: Review

References (80)

1. ALVAREZ, H.; CASTRO, C.; MOUJIR, L.; PERERA, A.; DELGADO, A.; SORIANO, I.; EVORA, C.; SANCHEZ, E. Efficacy of ciprofloxacin implants in treating experimental osteomyelitis. J. Biomed. Mater. Res. B. Appl. Biomater., v.85, n.1, p.93-104, 2008.
2. AMBROSE, C.G.; CLYBURN, T.A.; LOUDEN, K.; JOSEPH, J.; WRIGHT, J.; GULATI, P.; GOGOLA, G.R.; MIKOS, A.G. Effective Treatment of osteomyelitis with biodegradable microspheres in a rabbit model. Clin. Orthop. Relat. Res., v.421, p.293-299, 2004.
3. AMBROSE, C.G.; GOGOLA, G.R.; CLYBURN, T.A.; RAYMOND, A.K.; PENG, A.S.; MIKOS, A.G. Antibiotic Microspheres: Preliminary Testing for Potential Treatment of Osteomyelitis. Clin. Orthop. Relat. Res., v.415, p.279-285, 2003.
4. ANAGNOSTAKOS, K.; FÜRST, O.; KELM, J. Antibiotic-impregnated PMMA hip spacers. Current status. Acta Orthop., v.77, n.4, p.628-637, 2006.
5. ARIAS, F.; MATA-ESSAYAG, S.; LANDAETA, M.E.; CAPRILES, C.H.; PÉREZ, C.; NÚÑEZ, M.J.; CARVAJAL, A.; SILVA, M. Candida albicans osteomyelitis: case report and literature review. Int. J. Infect. Dis., v.8, n.5, p.307-314, 2004.
6. ASLAM, S.; DAROUICHE, R.O. Antimicrobial therapy for bone and joint infections. Curr. Infect. Dis. Rep., v.11, n.1, p.7-13, 2009.
7. AZI, M.L.; JUNIOR, M.K.; MARTINEZ, R.; PACCOLA, C.A.J. Bone cement and gentamicin in the treatment of bone infection: background and in vitro study. Acta Ortop. Bras., v.18, n.1, p.31-34, 2010.
8. BARTH, R.E.; VOGELY, H.C.; HOEPELMAN, A.I.; PETERS, E.J. To bead or not to bead? Treatment of osteomyelitis and prosthetic joint-associated infections with gentamicin bead chains. Int. J. Antimicrob. Agents, v.38, n.5, p.371-375, 2011.
9. BRADY, R.A.; COSTERTON, J.W.; SHIRTLIFF, M.E. Osteomyelitis: clinical overview and mechanisms of infection persistence. Clin. Microbiol. Newsletter, v.28, n.9, p.65-72, 2006.
10. BRIN, Y.S.; GOLENSER, J.; MIZRAHI, B.; MAOZ, G.; DOMB, A.J.; PEDDADA, S.; TUVIA, S.; NYSKA, A.; NYSKA, M. Treatment of osteomyelitis in rats by injection of degradable polymerreleasing gentamicin. J. Control. Release, v.131, n.2, p.121-127, 2008.
11. BROOK, I. Microbiology and management of joint and bone infections due to anaerobic bacteria. J. Orthop. Sci., v.13, n.2, p.160-169, 2008.
12. CALHOUN, J.H.; MANRING, M.M. Adult osteomyelitis. Infect. Dis. Clin. North Am., v.19, n.4, p.765-786, 2005.
13. CAMPOCCIA, D.; MONTANARO, L.; SPEZIALE, P.; ARCIOLA, C.R. Antibiotic-loaded biomaterials and the risks for the spread of antibiotic resistance following their prophylactic and therapeutic clinical use. Biomaterials, v.31, n.25, p.6363-6377, 2010.
14. CARVALHO, V.C.; OLIVEIRA, P.R.D.; DAL-PAZ, K.; DE PAULA, A.P.; FÉLIX, C.S.F.; LIMA, L.L.M. Gram-negative osteomyelitis: clinical and microbiological profile. Braz. J. Infect. Dis., v.16, n.1, p.63-67, 2012.
15. CHIHARA, S.; SEGRETI, J. Osteomyelitis. Dis. Mon., v.56, n.1, p.5-31, 2010.
16. COURVALIN P. Vancomycin resistance in gram-positive cocci. Clin. Infect. Dis., v.42, suppl.1, p. S25-S34, 2006.
17. DARLEY, E.S.; MACGOWAN, A.P. Antibiotic treatment of gram-positive bone and joint infections. J. Antimicrob. Chemother., v.53, n.6, p.928-935, 2004.
18. EID, A.J.; BERBARI, E.F. Osteomyelitis: a review of pathophysiology, diagnostic modalities and therapeutic options. J. Med. Liban., v.60, n.1, p.51-60, 2012.
19. EFSTATHOPOULOS, N.; GIAMARELLOS-BOURBOULIS, E.; KANELLAKOPOULOU, K.; LAZARETTOS, I.; GIANNOUDIS, P.; FRANGIA, K.; MAGNISSALIS, E.; PAPADAKI, M.; NIKOLAOU, V.S. Treatment of experimental osteomyelitis by methicillin resistant Staphylococcus aureus with bone cement system releasing grepafloxacin. Injury, v.39, n.12, p.1384-1390, 2008.
20. FRAIMOW, H.S. Systemic Antimicrobial therapy in osteomyelitis. Semin. Plast. Surg., v.23, n.2, p.90-99, 2009.
21. FRANK, D.; MONTSKO, G.; JURICSKAY, I.; BORSICZKY, B.; CSEH, G.; KOCSIS, B.; NAGY, T.; NAGY, A.K.; KOVÁCS, G.L.; MISETA, A. Clindamycin release determined by high performance liquid chromatography from a novel low-cost local drug delivery system: a new potential treatment option for chronic osteomyelitis. J. Med. Liban., v.23, n.5, p.282-284, 2011.
22. FURUSTRAND, T.U.; CORVEC, S.; BETRISEY, B.; ZIMMERLI, W.; TRAMPUZ, A. Role of rifampin against propionibacterium acnes biofilm in vitro and in an experimental foreign-body infection model. Antimicrob. Agents Chemother., v.56, n.4, p.1885-1891, 2012.
23. GARVIN, K.; MIYANO, J.; ROBINSON, D.; GIGER, D.; NOVAK, J.; RADIO, S. Polylactide/polyglycolide antibiotic implants in the treatment of osteomyelitis. J. Bone Joint Surg Am., v.76, n.10, p.1500-1506, 1994.
24. GITELIS, S.; BREBACH, G.T. The treatment of chronic osteomyelitis with a biodegradable antibiotic-impregnated implant. J. Orthop. Surg., v.10, n.1, p.53-60, 2002.
25. GOGIA, J.S.; MEEHAN, J.P.; CESARE, P.E.; JAMALI, A.A. Local antibiotic therapy in osteomyelitis. Semin. Plast. Surg., v.23, n.2, p.100-107, 2009.
26. GOULD, I.M.; DAVID, M.Z.; ESPOSITO, S.; GARAU, J.; LINA, G.; MAZZEI, T.; PETERS, G. New insights into meticillin-resistant Staphylococcus aureus (MRSA) pathogenesis, treatment and resistance. Int. J. Antimicrob. Agents, v.39, n.2, p.96-104, 2012.
27. GURSEL, I.; KORKUSUZ, F.; TURESIN, F.; ALAEDDINOGLU, N.G.; HASIRCI, V. In vivo application of biodegradable controlled antibiotic releasesystems for the treatment of implant-related osteomyelitis. Biomaterials, v.22, n.1, p.73-80, 2001.
28. HAIDAR, R.; DER BOGHOSSIAN, A.D.; ATIYEH, B. Duration of post-surgical antibiotics in chronic osteomyelitis: empiric orevidence-based? Int. J. Infect. Dis., v.14, n.9, p.752-758, 2010.
29. HARTEMANN-HEURTIER, A.; SENNEVILLE, E. Diabetic foot osteomyelitis. Diabetes Metab., v.34, n.2, p.87-95, 2008.
30. HOLTOM, P.D.; PATZAKIS, M. Newer methods of antimicrobial delivery for bone and joint infections. Instr. Course. Lect., v.52, p.745-749, 2003.
31. JOOSTEN, U.; JOIST, A.; FREBEL, T.; BRANDT, B.; DIEDERICHS, S.; VON EIFF, C. Evaluation of an in situ setting injectable calcium phosphate as a new carrier material for gentamicin in the treatment of chronic osteomyelitis: studies in vitro and in vivo. Biomaterials, v.25, n.18, p.4287-4295, 2004.
32. JOOSTEN, U.; JOIST, A.; GOSHEGER, G.; LILJENQVIST, U.; BRANDT, B.; VON EIFF, C. Effectiveness of hydroxyapatite-vancomycin bone cement in the treatment of Staphylococcus aureus induced chronic osteomyelitis. Biomaterials, v.26, n.25, p.5251-5258, 2005.
33. JORGE, L.S.; CHUEIRE, A.G.; ROSSIT, A.R. Osteomyelitis: a current challenge. Braz. J. Infect. Dis., v.14, n.3, p.310-315, 2010.
34. KANELLAKOPOULOU, K.; GALANOPOULOSB, I.; SORANOGLOU, V.; TSAGANOS, T.; TZIORTZIOTI, V.; MARIS, I. PAPALOIS, A.; GIAMARELLOU, H.; GIAMARELLOS-BOURBOULIS, E.J. Treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus with a synthetic carrier of calcium sulphate (Stimulan®) releasing moxifloxacin. Int. J. Antimicrob. Agents, v.33, n.4, p.354-359, 2009.
35. KANELLAKOPOULOU, K.; GIAMARELLOS-BOURBOULIS, E.J. Carrier systems for the local delivery of antibiotics in bone infections. Drugs, v.59, n.6, p.1223-1232, 2000.
36. KAYA, M.; SIMSEK-KAYA, G.; GÜRSAN, N.; KIREÇÇI, E.; DAYI, E.; GÜNDOGDU, B. Local treatment of chronic osteomyelitis with surgical debridement and tigecycline-impregnated calciumhydroxyapatite: an experimental study. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., v.113, n.3, p.340-347, 2011.
37. KLEMM, K. Gentamicin-PMMA-beads in treating bone and soft tissue infections. Zentralbl. Chir., v.104, n.14, p.934-942, 1979.
38. KORKUSUZ, F.; UCHIDA, A.; SHINTO, Y.; ARAKI, N.; INOUE, K.; ONO, K. Experimental implant-related osteomyelitis treated by antibiotic-calcium hydroxyapatite ceramic composites. J. Bone Joint Surg., v.75, n.1, p.111-114, 1993.
39. KUNDU, B.; NANDI, S.K.; KUMAR, S.; DASGUPTA, S.; DATTA. S.; MUKHERJEE, P.; ROY, S.; SINGH, A.K.; MANDAL, T.K.; DAS, P.; BHATTACHARYA, R.; BASU, D. Macro-to-micro porous special bioactive glass and ceftriaxone-sulbactam composite drug delivery system for treatment of chronic osteomyelitis: an investigation through in vitro and in vivo animal trial. J. Mater. Sci. Mater. Med., v.22, n.3, p.705-720, 2011.
40. LABBÉ, J.; PERES, O.; LECLAIR, O.; GOULON, R.; SCEMAMA, P.; JOURDEL, F. Acute osteomyelitis in children: the pathogenesis revisited? Orthop. Traumatol. Surg. Res., v.96, n.3, p.268-275, 2010.
41. LAMP, K.C.; FRIEDRICH, L.V.; MENDEZ-VIGO, L.; RUSSO, R. Clinical experience with daptomycin for the treatment of patients with osteomyelitis. Am. J. Med., v.120, n.10, suppl.1, p. S13-S20, 2007.
42. LAVERY, L.A.; PETERS, E.J.; ARMSTRONG, D.G.; WENDEL, C.S.; MURDOCH, D.P.; LIPSKY, B.A. Risk factors for developing osteomyelitis in patients with diabetic foot wounds. Diabetes Res. Clin. Pract., v.83, n.3, p.347-352, 2009.
43. LAZZARINI, L.; LIPSKY, B.A.; MADER, J.T. Antibiotic treatment of osteomyelitis: what have we learned form 30 years of clinical trials? Int. J. Infect. Diseases, v.9, n.3, p.127-138, 2005.
44. LEW, D.P.; WALDVOGEL, F.A. Osteomyelitis: current concepts. N. Engl. J. Med., v.336, n.14, p.999-1007, 1997.
45. LEW, D.P.; WALDVOGEL, F.A. Osteomyelitis. Lancet, v.364, n.9431, p.369-379, 2004.
46. LINDFORS, N.C.; HYVÖNEN, P.; NYYSSÖNEN, M.; KIRJAVAINEN, M.; KANKARE, J.; GULLICHSEN, E.; SALO, J. Bioactive glass S53P4 as bone graft substitute in treatment of osteomyelitis. Bone, v.47, n.2, p.212-218, 2010.
47. MACNICOL, M.F.; WATTS, A.C. Haematogenous osteomyelitis. Surgery, v.23, n.1, p.25-30, 2005.
48. MADER, J.T.; LANDON, G.C.; CALHOUN, J. Antimicrobial treatment of osteomyelitis. Clin. Orthop. Relat. Res., v.295, p.87-95, 1993.
49. MÄKINEN, T.J.; VEIRANTO, M.; LANKINEN, P.; MORITZ, N.; JALAVA, J.; TÖRMÄLÄ, P.; ARO, H.T. In vitro and in vivo release of ciprofloxacin from osteoconductive bone defect filler. J. Antimicrob. Chemother., v.56, n.6, p.1063-1068, 2005.
50. MALIZOS, K.N.; GOUGOULIAS N.E.; DAILIANA, Z.H.; VARITIMIDIS, S.; BARGIOTAS, K.A.; PARIDIS, D. Ankle and foot osteomyelitis: Treatment protocol and clinical results. Injury-Int. J. Care. Injured, v.41, n.3, p.285-293, 2010.
51. MARRA, F.; ROBBINS, G.M.; MASRI, B.A.; DUNCAN, C.; WASAN, K.M.; KWONG, E.H.; JEWESSON, P.J. Amphotericin B-loaded bone cement to treat osteomyelitis caused by Candida albicans. Can. J. Surg., v.44, n.5, p.383-386, 2001.
52. MCNALLY, M.; NAGARAJAH, K. Osteomyelitis. Orthop. Trauma, v.24, n.6, p.416-429, 2010.
53. MCPHEE, S.; PAPADAKIS, M. Current medical diagnosis and treatment. McGraw Hill editor, 2007. p.880-882.
54. MIYAI, T.; ITO, A.; TAMAZAWA, G.; MATSUNO, T.; SOGO, Y.; NAKAMURA, C.; YAMAZAKI, A.; SATOH, T. Antibiotic-loaded poly-ε-caprolactone and porous β-tricalcium phosphate composite for treating osteomyelitis. Biomaterials, v.29, n.3, p.350-358, 2008.
55. MOENSTER, R.P.; LINNEMAN, T.W.; FINNEGAN, P.M.; MCDONALD, J.R. Daptomycin compared to vancomycin for the treatment of osteomyelitis: a single-center, retrospective cohort study. Clin. Ther., v.34, n.7, p.1521-1527, 2012.
56. MOISE, P.A.; NORTH, D.; STEENBERGEN, J.N.; SAKOULAS, G. Susceptibility relationship between vancomycin and daptomycin in staphylococcus aureus: facts and assumptions. Lancet Infect. Dis., v.9, n.10, p.617-624, 2009.
57. MONTANARO, L.; TESTONI, F.; POGGI, A.; VISAI, L.; SPEZIALE, P.; ARCIOLA, C.R. Emerging pathogenetic mechanisms of the implant-related osteomyelitis by Staphylococcus aureus. Int. J. Artif. Organs, v.34, n.9, p.781-788, 2011.
58. MOUZOPOULOS, G.; KANAKARIS, N.K.; KONTAKIS, G.; OBAKPONOVWE, O.; TOWNSEND, R.; GIANNOUDIS, P.V. Management of bone infections in adults: the surgeon's and microbiologist's perspectives. Injury-Int. J. Care Injured, v.42, suppl.5, p. S18-S23, 2011.
59. NAIR, M.B.; KRETLOW, J.D.; MIKOS, A.G.; KASPER, F.K. Infection and tissue engineering in segmental bone defects-a mini review. Curr. Opin. Biotechnol., v.22, n.5, p.721-725, 2011.
60. NANDI, S.K.; MUKHERJEE, P.; ROY, S.; KUNDU, B.; DE, D.K.; BASU, D. Local antibiotic delivery systems for the treatment of osteomyelitis-a review. Mat. Sci. Eng C., v.29, n.8, p.2478-2485, 2009.
61. NELSON, C.L.; MCLAREN, S.G.; SKINNER R.A.; SMELTZER M.S.; THOMAS J.R.; OLSEN, K.M. The treatment of experimental osteomyelitis by surgical debridementand the implantation of calcium sulfate tobramycin pellets. J. Orthop. Res., v.20, n.4, p.643-647, 2002.
62. PÄÄKKÖNEN, M.; PELTOLA, H. Antibiotic treatment for acute haematogenous osteomyelitis of childhood: moving towards shorter courses and oral administration. Int. J. Antimicrob. Agents, v.38, n.4, p.273-280, 2011.
63. PAWAR, D.; BHANDARI, P. Newer antibiotics for musculoskeletal infections. Indian J. Rheumatol., v.6, n.1, p.80-86, 2011.
64. RICE, L.B. Antimicrobial resistance in gram-positive bacteria. Am. J. Med., v.119, n.6, suppl.1, p. S11-S19, 2006.
65. RIEGELS-NIELSEN, P.; ESPERSEN, F.; HÖLMICH, L.R.; FRIMODT-MØLLER, N. Collagen with gentamicin for prophylaxis of postoperative infection-Staphylococcus aureus osteomyelitis studied in rabbits. Acta Orthop. Scand., v.66, n.1, p.69-72, 1995.
66. SAMUEL, S.; MATHEW, B.S.; VEERARAGHAVAN, B.; FLEMING, D.H.; SAMUEL, B.; CHITTARANJAN, S.B.; PRAKASH, J.A. In vitro study of elution kinetics and bio-activity of meropenem-loaded acrylic bone cement. J. Orthopaedics Traumatol., v.13, n.3, p.131-136, 2012.
67. SÁNCHEZ, E.; BARO, M; SORIANO, I.; PERERA, A.; ÉVORA, C. In vivo-in vitro study of biodegradable and osteointegrable gentamicin bone implants. Eur. J. Pharm. Biopharm., v.52, n.2, p.151-158, 2001.
68. SCHADE, V.L.; ROUKIS, T.S. The role of polymethylmethacrylate antibiotic-loaded cement in addition to debridement for the treatment of soft tissue and osseous infections of the foot and ankle. J. Foot Ankle Surg., v.49, n.1, p.55-62, 2010.
69. SHIRTLIFF, M.E.; CALHOUN, J.H.; MADER, J.T. Experimental osteomyelitis treatment with antibiotic-impregnated hydroxyapatite. Clin. Orthop. Relat. Res., v.401, p.239-247, 2002.
70. SIA, I. G; BERBARI, E.F. Osteomyelitis. Best Pract. Res. Clin. Rheumatol., v.20, n.6, p.1065-1081, 2006.
71. TICE, A.D.; HOAGLUND, P. A; SHOULTZ, D.A. Risk factors and treatment outcomes in osteomyelitis. J. Antimicrob. Chemother., v.51, n.5, p.1261-1268, 2003a.
72. TICE, A.D.; HOAGLUND, P.A.; SHOULTZ, D.A. Outcomes of osteomyelitis among patients treated with outpatient parenteral antimicrobial therapy. Am. J. Med., v.114, n.9, p.723-728, 2003b.
73. VILHENA, C.; BETTENCOURT, A. Daptomycin: a review of properties, clinical use, drug delivery and resistance. Mini. Rev. Med. Chem., v.12, n.3, p.202-209, 2012.
74. WALENKAMP, G.H.I.M. Self-mixed antibiotic bone cement: western countries learn from developing countries. Acta Orthop., v.80, n.5, p.505-507, 2009.
75. WRIGHT, J.A.; NAIR S.P. Interaction of staphylococci with bone. Int. J. Med. Microbiol., v.300, n.2-3, p.193-204, 2010.
76. XIE, Z.; LIU, X.; JIA, W.; ZHANG, C.; HUANG, W. Vancomycin-loaded bioactive borate glass for treatment of chronic osteomyelitis in rabbit. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, v.25, n.7, p.830-836, 2011.
77. XIE, Z.; LIU, X.; JIA, W.; ZHANG, C.; HUANG, W.; WANG, J. Treatment of osteomyelitis and repair of bone defect by degradable bioactive borateglass releasing vancomycin. J. Controlled Release, v.139, n.2, p.118-126, 2009.
78. YIN, L.Y.; LAZZARINI, L.; Li, F.; STEVENS, C.M.; CALHOUN, J.H. Comparative evaluation of tigecycline and vancomycin, with and without rifampicin, in the treatment of methicillin resistant Staphylococcus aureus experimental osteomyelitis in a rabbit model. J. Antimicrob. Chemother., v.55, n.6, p.995-1002, 2005.
79. ZHANG, X.; JIA, W.; GU, Y.; XIAO, W.; LIU, X.; WANG, D.; ZHANG, C.; HUANG, W.; RAHAMAN, M.N.; DAY, D.E.; ZHOU, N. Teicoplanin-loaded borate bioactive glass implants for treating chronic bone infection in a rabbit tibia osteomyelitis model. Biomaterials, v.31, n.22, p.5865-5874, 2010.
80. ZIMMERLI, W. Vertebral osteomyelitis. N. Engl. J. Med., v.362, n.11, p.1022-1029, 2010.